DOC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Healthpeak Properties, Inc (DOC) is not a strong buy for a beginner, long-term investor at this moment. While the stock has some positive elements, such as bullish moving averages and sustainability achievements, the lack of strong growth trends, muted earnings forecasts, and mixed analyst sentiment make it less compelling. For an impatient investor unwilling to wait for optimal entry points, holding off for now is prudent.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), but the MACD histogram is negative and expanding downward (-0.118), indicating bearish momentum. RSI is neutral at 38.111, suggesting no clear signal. The stock is trading near its support level (S1: 19.507), with resistance at R1: 20.66.
BMO Capital raised its price target to $24, citing strong supply/demand fundamentals for REITs. Positive leasing trends in the life sciences portfolio could improve outlook if market conditions exceed expectations.
Morgan Stanley downgraded the stock to Equal Weight, citing elevated leasing costs, concessions, and potential downtimes as headwinds. Analysts expect muted earnings growth due to interest costs and capital recycling. Mixed analyst ratings and price targets reflect uncertainty in the stock's near-term performance.
No financial data available for the latest quarter. However, analysts have noted muted earnings growth and headwinds in the life sciences leasing market.
Analyst sentiment is mixed. While some firms like BMO Capital and Scotiabank raised price targets, others like Morgan Stanley and Evercore ISI downgraded the stock, citing limited upside and challenges in the life sciences leasing market.
